| HARP |    | Harpoon Therapeutics, Inc. - Common Stock | | | -0.57% up -2.26% 1.69 | | + T cell-based, Medicine, Immunology, Cancer fight, Disease: Oncology
Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1708493/000119312523284289/0001193125-23-284289-index.htm
8-K - Harpoon Therapeutics, Inc. (0001708493) (Filer) | + My List |
| IOVA | | Iovance Biotherapeutics, Inc. - Common Stock | | | 2.64% up 0.66% 1.98 | | + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based
Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1425205/000155837023018029/0001558370-23-018029-index.htm
10-Q - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer) | + My List |
| GRCL | | Gracell Biotechnologies Inc. - American Depositary Shares | | | 0.62% up 0.00% 0.62 | | + Biopharma, Biotechnology, Disease: Oncology, Cancer fight, T cell-based
Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1826492/000110465923117505/0001104659-23-117505-index.htm
6-K - Gracell Biotechnologies Inc. (0001826492) (Filer) | + My List |
| CNTB | | Connect Biopharma Holdings Limited - American Depositary Shares | | | -4.35% down -0.87% -3.48 | | + Biopharma, Country: China, T cell-based
Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1835268/000095017023065293/0000950170-23-065293-index.htm
6-K - Connect Biopharma Holdings Ltd (0001835268) (Filer) | + My List |
| LVTX | | LAVA Therapeutics N.V. - Ordinary Shares | | | 2.00% up 0.00% 2 | | + T cell-based, Cancer fight, Medicine, Disease: Oncology
Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1840748/000155837023019159/0001558370-23-019159-index.htm
6-K - LAVA Therapeutics NV (0001840748) (Filer) | + My List |
| BTMD | | Biote Corp. - Class A common stock | | | 3.61% up 2.40% 1.21 | | + T cell-based, Biotechnology, Immunology, Medicine
| + My List |
